YARROW BIOSCIENCE, INC. Interest Expense
YARROW BIOSCIENCE, INC. (YARW) reported Interest Expense of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-14.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2023-03-14
- YARROW BIOSCIENCE, INC. interest expense for the quarter ending 2022-12-31 was $0.00.
- YARROW BIOSCIENCE, INC. interest expense for the quarter ending 2022-09-30 was $0.00, a 100.00% decline year-over-year.
- YARROW BIOSCIENCE, INC. interest expense for the quarter ending 2022-06-30 was $0.00, a 100.00% decline year-over-year.
- YARROW BIOSCIENCE, INC. interest expense for the quarter ending 2022-03-31 was $0.00, a 100.00% decline year-over-year.
- YARROW BIOSCIENCE, INC. interest expense for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- YARROW BIOSCIENCE, INC. interest expense for fiscal 2021 was $5.61M, a 27.79% increase from fiscal 2020.
- YARROW BIOSCIENCE, INC. interest expense for fiscal 2020 was $4.39M, a 376.66% increase from fiscal 2019.
- YARROW BIOSCIENCE, INC. interest expense for fiscal 2019 was $921.00K.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $0.00 derived: sum of 2 quarters · filed 2023-03-14 | $0.00 derived: sum of 3 quarters · filed 2023-03-14 | $0.00 10-K · filed 2023-03-14 |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-14 | $0.00 derived: sum of 2 quarters · filed 2022-11-14 | $0.00 10-Q · filed 2022-11-14 | $0.00 derived: sum of 4 quarters · filed 2023-03-14 |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-12 | $0.00 10-Q · filed 2022-08-12 | $0.00 derived: sum of 3 quarters · filed 2023-03-14 | $3.47M derived: sum of 4 quarters · filed 2023-03-14 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-12 | $0.00 derived: sum of 2 quarters · filed 2023-03-14 | $3.47M derived: sum of 3 quarters · filed 2023-03-14 | $4.55M derived: sum of 4 quarters · filed 2023-03-14 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $3.47M derived: sum of 2 quarters · filed 2023-03-14 | $4.55M derived: sum of 3 quarters · filed 2023-03-14 | $5.61M 10-K · filed 2023-03-14 |
| 2021-09-30 | $3.47M 10-Q · filed 2022-11-14 | $4.55M derived: sum of 2 quarters · filed 2022-11-14 | $5.61M 10-Q · filed 2022-11-14 | $6.77M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $1.07M 10-Q · filed 2022-08-12 | $2.14M 10-Q · filed 2022-08-12 | $3.30M derived: sum of 3 quarters · filed 2022-08-12 | $4.39M derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-03-31 | $1.06M 10-Q · filed 2022-05-12 | $2.22M derived: sum of 2 quarters · filed 2022-05-12 | $3.31M derived: sum of 3 quarters · filed 2022-05-12 | $4.38M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $1.16M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $2.25M derived: sum of 2 quarters · filed 2022-03-17 | $3.32M derived: sum of 3 quarters · filed 2022-03-17 | $4.39M 10-K · filed 2022-03-17 |
| 2020-09-30 | $1.09M 10-Q · filed 2021-11-10 | $2.16M derived: sum of 2 quarters · filed 2021-11-10 | $3.23M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $1.07M 10-Q · filed 2021-08-12 | $2.14M 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | $1.07M 10-Q · filed 2021-05-06 | |||
| 2019-12-31 | $921.00K 10-K · filed 2021-03-04 | |||
| 2018-12-31 | $0.00 10-K · filed 2021-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |